Biotech Business Daily (BIIB, GSK, ILMN, IVGN, LJPC, SIRT, STEM)
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates ...Read Full Story »

